Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980–2022
by: Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, John H. Powers
| Format: | Article |
|---|---|
| Published: | Nature Portfolio 2024-02-01 |
Tab content not available
Tab content not available
Tab content not available
Tab content not available
Tab content not available